Ol'GA N. Krasnorutskaya

Ol'GA N. Krasnorutskaya

Auto-generated profile, based on publicly available information

Ol'GA N. Krasnorutskaya

Voronezh State Medical University named after N. N. Burdenko

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2021 in I.P. Pavlov Russian Medical Biological Herald
Verified
Journal Article
Closed access
PDF file
AFAnna G. Faustova
Anna G. Faustova
OKOl'GA N. Krasnorutskaya
Ol'GA N. Krasnorutskaya
Background: Psychological trauma may cause noticeable damage to the hippocampus, amygdala, and prefrontal cortex. Brain-derived neurotrophic factor (BDNF) demonstrates neuroprotective properties in relation to organic brain damage caused by ischemia and craniocerebral traumas. To date, no sufficient evidence suggests that BDNF provides the viability of the nervous system in the process of overcoming the negative consequences of psychotraumatic events. Aim: To analyze the relationshipbetween the individual psychological manifestations of the "resilient phenotype" and the BDNF level in the blood serum of individuals who have psychological traumatic experience and demonstrate effective coping. Materials and methods: In 33 respondents (26 women, 7 men; mean age, 26.3 7.46 years) who had psychological traumatic experience in the previous 3 years, the BDNF level (determined by quantitative enzyme-linked immunosorbent assay), personality, and behavioral correlates of psychological resilience were explored (using psychological survey). Correlation and multiple regression analyses were used in the mathematical and statistical processing of empirical data. Results: The BDNF level in the blood serum of individuals with a past psychotraumatic event serves as a predictor of the level of expressiveness of resistance to stress (t=2.093, р=0.045), maladaptive states (t=2.511, р=0.018), manifestations of post-traumatic growth ("Personal Strength", t=2.911, р=0.007; "New Opportunities", t=2.242, р=0.032), and psychological well-being (t=3.106, р=0.004). Conclusion: The practical significance of the study is attributed to the formation of evidence base for clinical psychology, improvement of approaches to diagnostics, and provision of clinical and psychological assistance to those affected by psychotraumatic events.

17 February 2023 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
TKT.I. Kurdiukova
T.I. Kurdiukova
OKO.N. Krasnorutskaia
O.N. Krasnorutskaia
This bibliographical review provides an analysis of modern domestic and foreign sources on the microbiome of the upper respiratory tract (URT) in children of early and preschool ages. It was discovered using the genetic sequencing method that the mucous membranes of the URT are inhabited by a wide range of bacteria belonging to the genera Firmicutes, Actinobacteria, Bacteroidetes, Proteobacteria and Fusobacteria, with the predominant genera Moraxella, Haemophilus, Streptococcus, Flavobacteria, Corynebacterium and Neisseria. Colonization of the URT begins at birth and continues into the first 3 years of a child's life. It is influenced by the method of delivery as well as the environmental microbiome in the baby's environment. Normal microbiota has colonization resistance, prevents the colonization of pathogenic flora, and also competes with pathogens. It has been proven that microbiota profiles in infants and preschool children vary depending on the season. One of the important areas of research is the assessment of the impact of antiseptics and antibiotics, as well as probiotic preparations, on the microbiota.

21 January 2025 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
YBYu. V. Burenkov
Yu. V. Burenkov
VSV. I. Shevtsova
V. I. Shevtsova
OKO. N. Krasnorutskaya
O. N. Krasnorutskaya
YKYu. A. Kotova
Yu. A. Kotova
Over the past 50 years, the number of obese people has increased many times. Despite the excess weight, many patients may be metabolically healthy. But studies show that this condition is an intermediate stage ending with a metabolically unhealthy phenotype, which is associated with an increase in the incidence of cardiovascular events. The concept of metabolically unhealthy obesity is characterized by altered levels of various biomarkers, the significance of which in the context of predicting a metabolically unhealthy phenotype remains to be studied. The review is devoted to the analysis of modern research data on the role of hyperuricemia, gut microbiota and its metabolites, adipocytokines, as well as an assessment of their relationship with a metabolically unhealthy obesity.

15 January 2023 in Russian Journal of Child Neurology
Verified
Journal Article
Open access
PDF file
GGG. S. Golosnaya
G. S. Golosnaya
NEN. A. Ermolenko
N. A. Ermolenko
OKO. N. Krasnorutskaya
O. N. Krasnorutskaya
VEV. L. Efimova
V. L. Efimova
TLT. A. Larionova
T. A. Larionova
MTM. D. Tysyachina
M. D. Tysyachina
In this article, we report a case of CTNNB1 syndrome (CTNNB1-NDD) in a child with cerebral palsy and also provide a literature review on the problem. CTNNB1 syndrome is an exceedingly rare and poorly studied disorder, which makes it particularly interesting due the difficulties associated with its diagnosis and description of the disease phenotype, as well as highly polymorphic clinical manifestations. Verification of the diagnosis is important to determine the prognosis of a child with cerebral palsy and visual impairment, as well as for reproductive planning in the family.

9 November 2023 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
VBV.A. Bykova
V.A. Bykova
NEN.A. Ermolenko
N.A. Ermolenko
OKO.N. Krasnorutskaya
O.N. Krasnorutskaya
OZO.V. Zolotarev
O.V. Zolotarev
OSO.YU. Shiryaev
O.YU. Shiryaev
MAM.R. Abramova
M.R. Abramova
Objective. To study the clinical course, the rate of progression and the results of the disease modifying treatment (DMT) in pediatric-onset multiple sclerosis (POMS) patients in the Voronezh region. Material and methods. The clinical characteristics of the course of relapsing-remitting multiple sclerosis (MS) were analyzed among 51 POMS patients and 51 patients with the adult-onset MS (AOMS). The clinical course was assessed based on the Expanded Disability Status Scale (EDSS) score, the average annual frequency of exacerbations and the rate of disease progression before and during DMT. Results. There were no statistically significant differences in EDSS scores 11 years after the onset of MS between the groups: POMS patients achieved moderate disability by the age of 25, and AOMS patients showed stabilization of their condition during DMT by the age of 36. During changing first-line drugs in patients with POMS, there was again an increase in disability with the transition of 25% of patients to the group with secondary progression of MS on average after 8 years of DMT. Conclusion. The onset of the disease in children and adolescents leads to a significant decrease in their quality of life and the deterioration of all activities throughout their lives. To prevent the progression of the disease it seems appropriate to transfer patients with POMS immediately to second-line DMT when signs of a suboptimal response to first line DMT appear, and in the case of a rapidly progressive course to start therapy with second-line drugs.

31 March 2026 in Медицинский оппонент
Verified
Journal Article
Closed access
АКА.а. Куприянова
А.а. Куприянова
ОКО.н. Красноруцкая
О.н. Красноруцкая
ДБД.ю. Бугримов
Д.ю. Бугримов
В статье анализируется роль дезадаптивного тренированного иммунитета в патогенезе хронической обструктивной болезни легких (ХОБЛ) и формировании антибиотикорезистентности при инфекционных обострениях. Обосновано, что персистирующее нейтрофильное воспаление, опосредованное гиперпродукцией ИЛ-8, создает условия для селекции резистентных штаммов, что требует поиска патогенетических подходов к иммунокоррекции. Представлены результаты проспективного сравнительного исследования с участием 60 пациентов с ХОБЛ II–III стадии, распределенных на основную и контрольную группы по 30 человек. Показано, что включение дезоксирибонуклеата натрия (активатора TLR9) в стандартную схему терапии сопровождалось более выраженным клиническим улучшением: повышение сатурации до 97% против 95% в контроле (p=0,015), снижение интенсивности кашля (p=0,001) и нормализация реологии мокроты. Отмечена значимая коррекция иммунного ответа, проявлявшаяся снижением уровня ИЛ-8 с 12,5±2,3 до 5,4±1,36 пг/мл (p<0,001) и повышением α-интерферона с 6,6±0,8 до 8,8±1,1 пг/мл (p<0,01), что свидетельствует о переключении на Th1-фенотип. Доля резистентных штаммов снизилась с 40 до 10,3% (p<0,001), а микробная нагрузка — с 10⁶ до 5,5×10⁵ КОЕ/мл (p<0,001). Полученные данные подтверждают эффективность иммуномодулирующего подхода, направленного на преодоление дезадаптивного иммунитета и антибиотикорезистентности в комплексной терапии ХОБЛ.